- Home
- BRIA vs CPIX Comparison
BRIA vs CPIX Comparison
Compare BRIA & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRIA
- CPIX
- Stock Information
- Founded
- BRIA 2011
- CPIX 1999
- Country
- BRIA Singapore
- CPIX United States
- Employees
- BRIA N/A
- CPIX N/A
- Industry
- BRIA
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- BRIA
- CPIX Health Care
- Exchange
- BRIA NYSE
- CPIX Nasdaq
- Market Cap
- BRIA 73.0M
- CPIX 68.7M
- IPO Year
- BRIA 2024
- CPIX 2009
- Fundamental
- Price
- BRIA $2.09
- CPIX $4.36
- Analyst Decision
- BRIA
- CPIX
- Analyst Count
- BRIA 0
- CPIX 0
- Target Price
- BRIA N/A
- CPIX N/A
- AVG Volume (30 Days)
- BRIA 28.2K
- CPIX 112.7K
- Earning Date
- BRIA 05-15-2025
- CPIX 03-04-2025
- Dividend Yield
- BRIA N/A
- CPIX N/A
- EPS Growth
- BRIA N/A
- CPIX N/A
- EPS
- BRIA 92.24
- CPIX N/A
- Revenue
- BRIA $55,755,669.00
- CPIX $37,867,945.00
- Revenue This Year
- BRIA N/A
- CPIX N/A
- Revenue Next Year
- BRIA N/A
- CPIX N/A
- P/E Ratio
- BRIA $0.02
- CPIX N/A
- Revenue Growth
- BRIA 8.03
- CPIX N/A
- 52 Week Low
- BRIA $1.85
- CPIX $1.04
- 52 Week High
- BRIA $4.38
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- BRIA N/A
- CPIX 44.29
- Support Level
- BRIA N/A
- CPIX $3.91
- Resistance Level
- BRIA N/A
- CPIX $4.47
- Average True Range (ATR)
- BRIA 0.00
- CPIX 0.34
- MACD
- BRIA 0.00
- CPIX -0.15
- Stochastic Oscillator
- BRIA 0.00
- CPIX 26.63
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.